Takeda | 4502 - Cost Of Sales


Takeda reported JPY517.6B in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Astellas Pharma JPY 158.38B 28.94B Jun/2026
Chugai Pharma JPY 104.22B 11.43B Jun/2026
Daiichi Sankyo JPY 124.29B 6.02B Jun/2026
Eisai JPY 51.09B 926M Jun/2026
Kyowa Hakko Kirin JPY 39.13B 6.13B Jun/2026
M3 JPY 45.64B 558M Jun/2026
Otsuka Holdings JPY 191.82B 17.73B Jun/2026
Shionogi JPY 46.62B 13.95B Jun/2026
Sumitomo Dainippon JPY 61.41B 10.15B Jun/2026
Takeda JPY 517.6B 42.94B Jun/2026
Terumo JPY 133.27B 18.03B Jun/2026